Emerging studies suggest this peptide, a dual agonist targeting both GLP-1 and GIP , may represent a notable step forward for body loss . Initial human investigations have demonstrated considerable https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026